Anesthesia and Postoperative Delirium in Parkinson DBS

Parkinson's disease (PD) is the second most common neurodegenerative disorder, with a rising incidence due to global aging. Deep Brain Stimulation (DBS) of the subthalamic nucleus (STN) is a core therapeutic modality for motor symptoms in patients with moderate-to-advanced PD. However, Postoperative Delirium (POD) is a common and significant complication following DBS surgery, affecting up to 42.6% of patients. POD is associated with prolonged hospitalization, increased medical costs, and poorer neurological prognosis. Current evidence regarding the incidence of POD after STN-DBS and the impact of different anesthesia management strategies remains limited, with a lack of large-scale prospective studies. This study aims to prospectively investigate the incidence, risk factors, and anesthesia-related neuroprotective mechanisms of POD in PD patients undergoing STN-DBS. Specifically, the study seeks to: Determine the incidence of POD within 3 days postoperatively. Analyze the correlation between anesthesia management (including anesthetic agents, depth, and hemodynamics) and the occurrence of POD. Explore the interaction between POD and postoperative non-motor symptoms such as pain, sleep disturbances, and long-term cognitive function. Construct a multidimensional prediction model for POD based on preoperative and intra-operative data.

Inclusion Criteria: * Aged 50-80 years old * American Society of Anesthesiologists (ASA) physical status classification II-III * Scheduled for bilateral subthalamic nucleus deep brain stimulation (STN-DBS) for Parkinson's disease * Signed informed consent prior to enrollment Exclusion Criteria: * Obstructive sleep apnea * Body mass index (BMI) \>30 kg/m² * Predicted difficult airway * Severe preoperative anxiety * Severe dysfunction of vital organs (e.g., heart failure, renal or hepatic dysfunction) * History of allergy to anesthetic agents